Naumann Chaudry

Naumann Chaudry is an experienced regulatory affairs professional currently serving as Vice President of Global Regulatory Affairs at Vertex Pharmaceuticals since September 2024. Previously held the position of Vice President and Head of US Regulatory Affairs at MorphoSys from March 2023 to September 2024, and Vice President for both Global and US Regulatory Affairs at Takeda in 2022. At Gilead Sciences, Naumann Chaudry held several senior roles from December 2011 to March 2022, including Executive Director for Global RA Strategy in Inflammation, and led regulatory affairs advertising and promotion teams in the US and Canada. Naumann Chaudry's career began at Pfizer Pharmaceuticals, including various positions in regulatory strategy from June 2001 to June 2010, and experience as a Clinical Research Fellow at PPD. Naumann Chaudry holds a PharmD in Pharmacy from Rutgers University and a Clinical Research Fellowship from the University of North Carolina at Chapel Hill.